Question 1

What does peer-reviewed research say about these claims?

Accepted Answer

Bro translation: Mainstream literature does not support a chiropractic clinic claiming broad diabetes or metabolic disease management through functional medicine, DNA/metabolic testing, supplements, and glucose monitoring as a substitute for standard medical care. Continuous glucose monitors can be useful in specific diabetes and metabolic contexts, but marketing them as a general wellness optimization tool for “inflammation control” and “balancing blood sugar” goes well beyond what evidence-based guidelines support. Hyperbaric oxygen, EMSELLA, and spinal decompression each have narrow indications; bundling them into a general internal-medicine-style program is not backed as a comprehensive treatment model.

Question 2

Are Teresa Marie Volner's credentials legitimate?

Accepted Answer

Teresa Volner is presented as a doctor and diabetes authority, but the page does not clearly establish an MD or DO license. The bigger problem is credential inflation by implication: the site uses that title to market internal-medicine-style diabetes management, genetic interpretation, detox, and supplement selection as if broad medical competence were established. Stated credentials: DR. Likely credentials: Chiropractor (DC), DC. Credential inflation detected, a white coat is not the same as an MD/DO license.

Question 3

Is Dr Teresa Marie Volner a real medical doctor?

Accepted Answer

Teresa Marie Volner is not identified as an MD/DO physician in reviewed credentials or public registry data. Likely credential: Chiropractor (DC).

Question 4

Does Teresa Marie Volner use Fear Mongering?

Accepted Answer

This frames everyday glucose variation as a broad wellness threat and uses it to justify ongoing monitoring and intervention. Likely motive: Move viewers toward CGM sales, coaching, and repeat follow-up

Question 5

Does Teresa Marie Volner use Lab Test Upsell?

Accepted Answer

The page pushes testing as the key to unlocking hidden causes, a classic diagnostic upsell that can lead into more purchases and visits. Likely motive: Sell high-margin testing and downstream protocols

Question 6

Does Teresa Marie Volner use Proprietary Product Funnel?

Accepted Answer

A vague branded supplement protocol invites recurring product sales while sounding individualized and medically tailored. Likely motive: Create a recurring supplement revenue stream

Question 7

Is the claim "to help you achieve safe, effective, and sustainable long-term results" supported by medical literature?

Accepted Answer

The influencer’s statement is a very general promise (“safe, effective, and sustainable long‑term results”) and not a specific medical claim, so it cannot be directly tested in clinical trials or guidelines. However, major guidelines across different areas of medicine consistently emphasize that any recommended intervention should balance efficacy with safety and long‑term sustainability, which loosely aligns with the principles mentioned in the claim. For example, guideline‑driven management of hypertension prioritizes evidence‑based therapies that lower blood pressure and reduce cardiovascular events while minimizing adverse effects and supporting long‑term adherence. Nutrition guidelines for hospitalized or critically ill patients similarly promote individualized, evidence‑based nutrition support that aims at effective clinical outcomes and safety over the long term. Clinical nutrition guidelines in chronic diseases such as inflammatory bowel disease focus on sustainable, patient‑tailored approaches rather than short‑term, extreme measures. Headache treatment guidelines also stress using therapies with acceptable safety profiles and long‑term management strategies rather than short‑term symptomatic relief alone. Transfusion practice guidance and pericarditis treatment summaries both reflect the same general principle: use interventions where the expected benefit justifies the risks and where there is adequate evidence for both effectiveness and safety. The GRADE framework explicitly rates the quality of evidence and considers imprecision and other domains to ensure that guideline recommendations are tied to robust evidence about benefits, harms, and sustainability of effects. Because the influencer’s statement is vague and does not specify a particular intervention, dose, population, or outcome, there is no direct high‑quality evidence specifically showing that whatever they are promoting will reliably yield safe, effective, and sustainable long‑term results. Guidelines for hypertension, clinical nutrition, headache, transfusion therapy, and pericarditis all show that such outcomes depend on careful trial data, patient selection, monitoring, and adherence, and they caution against assuming safety and long‑term effectiveness without rigorous evaluation. The GRADE framework highlights that claims of effectiveness and safety must be tempered when evidence is imprecise, of low quality, or indirect, underscoring that broad promises without specific supporting data are not considered reliable in mainstream evidence‑based medicine. Therefore, the influencer’s generic promise overstates the certainty that can be claimed without presenting concrete, evidence‑based details about the intervention and the data backing it. Mainstream evidence‑based medicine holds that for any health intervention, the goals are to achieve clinically meaningful benefits while minimizing harms and supporting long‑term adherence and outcomes, but such claims must be supported by specific, high‑quality evidence (RCTs, systematic reviews, and well‑developed guidelines) tied to clearly defined interventions and populations. Frameworks like GRADE are used to formally rate the certainty of evidence and prevent overconfident, generic promises about safety and long‑term effectiveness when data are limited, indirect, or imprecise. As a result, broad influencer statements that something will help you achieve safe, effective, and sustainable long‑term results are not accepted at face value in mainstream medicine unless they correspond to a specific intervention with robust supporting data and guideline endorsement. Literature verdict: unsupported.

Question 8

Is the claim "Use Stelo on its own or combine it with Total Care’s holistic health solutions includin…" supported by medical literature?

Accepted Answer

Stelo is an FDA-cleared over‑the‑counter integrated continuous glucose monitor (iCGM) intended to track glucose continuously in adults not on insulin, primarily for people with prediabetes or type 2 diabetes who are not on insulin therapy. Early observational data from Stelo users show that adults with non–insulin-treated type 2 diabetes and suboptimal glycemic control had a clinically meaningful increase in time in range over the first 30 days of Stelo use, suggesting that CGM-based lifestyle feedback can support improvements in glycemic control. More broadly, continuous glucose monitoring and related digital interventions can be used as part of lifestyle and metabolic programs to improve diabetes self-management, and randomized trials of personalized dietary advice based on CGM data in newly diagnosed type 2 diabetes demonstrate improved HbA1c, self‑care behaviors, and patient satisfaction compared with standard education. Systematic reviews and meta-analyses of mobile health interventions for diabetes and hypertension report that structured digital monitoring and feedback programs can improve clinical outcomes such as glycemic control and blood pressure, supporting the idea that technology-based monitoring tools can be integrated into broader wellness or metabolic programs. Comprehensive employee health management programs targeting cardiometabolic risk factors (including lifestyle, metabolic, and wellness components) have been systematically reviewed and can provide benefits in cardio-metabolic risk profiles, indicating that multidimensional programs addressing behavior, metabolism, and overall wellness can be effective when properly designed and evidence-based. The claim specifically promotes combining Stelo with a chiropractic, metabolic, and wellness program, but there is no high‑quality evidence showing that chiropractic care itself improves glycemic control, insulin resistance, or other core metabolic outcomes in diabetes or prediabetes; chiropractic is not recognized by major diabetes or endocrine guidelines as an evidence‑based metabolic therapy. Existing high-quality evidence supports CGM and digital lifestyle interventions, but the available data for Stelo are limited to short‑term observational analyses from early adopters rather than randomized controlled trials, and therefore do not establish that Stelo alone or in combination with holistic chiropractic programs improves long‑term cardiometabolic outcomes or reduces diabetes complications. Systematic reviews of mHealth and CGM‑based interventions emphasize structured, protocol‑driven programs with professional oversight and clear behavioral targets; these data cannot be extrapolated to unstructured commercial “holistic” packages that include modalities (such as chiropractic) without proven metabolic benefits. Major employee cardiometabolic programs reviewed in the literature focus on lifestyle, medical risk factor management, and behavioral change; they do not include chiropractic as a core evidence‑based component of metabolic treatment. Overall, the evidence base does not support claims that combining Stelo with chiropractic and generic wellness programs will reliably produce better long‑term metabolic or overall health outcomes than standard guideline‑based care plus appropriate use of CGM and lifestyle interventions. Mainstream medical and scientific opinion is that continuous glucose monitoring can be a useful adjunct for selected people with diabetes or prediabetes to improve self‑management, guide dietary and activity changes, and potentially improve glycemic control when used within structured, evidence‑based programs and with appropriate clinical oversight. Stelo, as an OTC CGM/iCGM, is viewed as a lifestyle and learning tool rather than a stand‑alone medical therapy, and its early data suggest potential benefits but require stronger evidence before it can be considered a proven intervention for long‑term metabolic outcomes. Standard diabetes and cardiometabolic care relies on guideline‑directed pharmacotherapy, nutrition therapy, physical activity, weight management, and management of blood pressure and lipids, often supported by digital tools and CGM where appropriate; chiropractic care is generally not part of evidence‑based metabolic or diabetes treatment recommendations and is considered outside mainstream cardiometabolic management. Mainstream practice accepts multidisciplinary “wellness” or metabolic programs only when their components are individually evidence‑based, monitored, and aligned with established clinical guidelines; marketing claims that pairing CGM devices with chiropractic and loosely defined holistic wellness programs will enhance long‑term health are viewed as unsupported and extrapolative. Literature verdict: mixed.

Advertised	Verdict
Listed service Diabetes and metabolic Wellness Rule: KSA 65-2871 Diagnosing and treating systemic metabolic disease like diabetes falls outside chiropractic scope; the statute limits chiropractors to physical manipulation, physiotherapy, and foods/food extracts, not management of endocrine or metabolic disorders.	Outside scope
Listed service Winners in Diabetes® Rule: KSA 65-2871 A branded program or service for diabetes management represents diagnosis and treatment of systemic metabolic disease, which is outside chiropractic scope.	Outside scope
Diagnosing and treating diabetes/metabolic disease as a chiropractic clinic service Rule: KSA 65-2871 Diagnosis and treatment of systemic metabolic disease is not within the statutory scope of chiropractic practice in Kansas, which is limited to musculoskeletal manipulation and physiotherapy.	Outside scope
Functional medicine for diabetes and metabolic wellness Rule: KSA 65-2871 Functional medicine as a primary-care or disease-management approach for systemic conditions is outside chiropractic scope; chiropractors are limited to manual manipulation and physiotherapy.	Outside scope
Listed service Functional Medicine Rule: KSA 65-2871 Functional medicine as a distinct medical practice modality is outside chiropractic scope; the statute does not authorize chiropractors to practice medicine or provide primary medical care.	Outside scope
Listed service Personalized DNA & Metabolic Testing Rule: KSA 65-2871 Genetic and metabolic testing for disease diagnosis and management is a medical diagnostic service outside chiropractic scope; chiropractors are limited to physical examination, X-ray analysis, and manual assessment.	Outside scope
Listed service Hyperbaric Oxygen Therapy Rule: KSA 65-2871 Hyperbaric oxygen therapy is a medical treatment modality not listed in the chiropractic scope statute; it is not manual manipulation, physiotherapy, or use of foods/food extracts.	Outside scope
Listed service Naturopathic medicine Rule: KSA 65-2871 Naturopathic medicine is a distinct healing art not authorized for chiropractors in Kansas; the statute does not grant chiropractors a license to practice naturopathy.	Outside scope

Teresa Marie Volner alias The Glucose Chiro

Score breakdown

Key findings

Claims & evidence

Manipulation

Borrowed authority & guest funnel

Host self-funnel

Commerce & grift map

Zocdoc

Supplements pitched

Labs pitched

How the money flows

Store links detected

Sponsors and advertisers

Credentials & scope

Permitted scope vs advertised

What this license permits

Scope comparison mirror

Validated associated properties

Analyzed

Funnel routes (third-party)

Tip the jar

Fight disinformation

Log a new mention

Reply snippets

Recent mentions (this doc)

Nudge the Doc Bro

Pick a contact address

What gets sent

Know someone who can help?

Who should we nudge?

What gets sent

Whambulance

Public challenge log

File a challenge

Citations